Medical Research News

RSS

Exciting progress made in MS research during 2010

Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first therapy specifically approved to treat a symptom of MS (Ampyra).

20 Dec 2010

Health Care at Home: Trends and issues

Leaders in the nation's Health Care at Home movement outlined trends and issues during a webinar for physicians across the country today. The webinar, "Why Health Care is Going Home," offered industry insights and detailed the reasons why home care will play a major role in the future of health care in America.

20 Dec 2010

PwC: Top Health Industry Issues of 2011

Health organizations will undergo a strategy makeover in 2011 as they react to new rules and payment models, continuing cost pressures and new customer demands, according to the Top Health Industry Issues of 2011, published today by PwC's Health Research Institute. But in a recent nationwide survey of 1,000 U.S. adults, PwC found that consumers don't fully understand or buy-in to all the changes.

20 Dec 2010

U of A student wins annual master's thesis competition for research on light-sensitive drug for prostate cancer

The future of cancer treatment and a University of Alberta graduate student's personal career prospects are looking bright. Weiyang Liu beat competitors from 80 of the best university graduate schools in western North America with his master's thesis on the use of a light-sensitive drug to treat prostate cancer.

20 Dec 2010

Researchers demonstrate that monensin antibiotic prevents prostate cancer cell growth

Researchers from VTT Technical Research Centre of Finland and the University of Turku have demonstrated that an antibiotic called "monensin" prevents the growth of prostate cancer cells. Monensin is used in the meat and dairy industry, for example.

20 Dec 2010

Sanofi-aventis, Oxford University to conduct multi-phase oncology research in India

Sanofi-aventis US and Oxford University have entered into an agreement to conduct multi-phase oncology clinical and epidemiological research with INDOX, India's leading academic oncology network.

20 Dec 2010

Avila, sanofi-aventis enter global alliance to discover targeted covalent drugs for treatment of cancers

Avila Therapeutics, Inc. announced today that it has signed a worldwide strategic alliance with sanofi-aventis to discover targeted covalent drugs for the treatment of cancers. Under the alliance agreement sanofi-aventis obtains a worldwide exclusive license to develop and commercialize the compounds resulting from the discovery collaboration.

20 Dec 2010

Researchers examine socio-economic consequences of hypersomnia

Danish sleep researchers at the University of Copenhagen and the Danish Institute for Health Services Research have examined the socio-economic consequences of the sleep disorder hypersomnia in one of the largest studies of its kind.

20 Dec 2010

Study finds second skin barrier structure may play a role in eczema development

Like a fence or barricade intended to stop unwanted intruders, the skin serves as a barrier protecting the body from the hundreds of allergens, irritants, pollutants and microbes people come in contact with every day.

20 Dec 2010

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

New research into the health benefits of beetroot juice suggests it's not only athletes who can benefit from its performance enhancing properties - its physiological effects could help the elderly or people with heart or lung-conditions enjoy more active lives.

20 Dec 2010

Improved brain-machine technologies

A new study published in the Dec 15 issue of The Journal of Neuroscience found that monkeys were able to move thought-controlled computer cursors more quickly and accurately when provided with additional sensory feedback.

19 Dec 2010

Completely fearless woman stirs scientific interest

It has been known since the 1930s that when a certain part of monkeys’ brains were removed, the animals became fearless. Now similar effects are being seen in humans according to a study in the journal Current Biology. Justin Feinstein, the study’s lead author and a clinical neuropsychologist at the University of Iowa said, “There’s not very many humans with this sort of brain damage… Luckily for us, we had access to a patient, SM, and we studied her different fear behaviours and we read her personal diaries.”

19 Dec 2010

Early intervention can improve core symptoms of ASD in young children: Study

In a study recently published in the Journal of Child Psychology and Psychiatry (Epub ahead of print), researchers from the Kennedy Krieger Institute found that early intervention can improve the core symptoms of autism spectrum disorders in very young children.

17 Dec 2010

NIAID renews funding of PRIME to develop mathematical models to study influenza infection

Mount Sinai School of Medicine today announced that the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has renewed funding of the Program for Research on Immune Modeling and Experimentation. This program seeks to develop easy-to-use, predictive mathematical models to better understand patterns of infection among individuals affected by the H1N1 and 1918 influenza viruses and other related viruses.

17 Dec 2010

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

DiaGenic ASA and Pfizer Inc today signed an agreement for explorative R&D collaboration to identify biomarkers in early stages of Alzheimer's disease (AD) using DiaGenic's patented gene expression technology and its blood samples from ongoing clinical studies.

17 Dec 2010

23andMe project aims at validating highly scalable pharmacogenomics research

23andMe has launched a project funded by the National Institutes of Health which is aimed at validating 23andMe's highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide Association Studies of Drug Response" from NIH's National Human Genome Research Institute.

17 Dec 2010

Study highlights death or rehospitalization rates for Medicare beneficiaries with ischemic stroke

Nearly two-thirds of Medicare beneficiaries discharged from hospitals after ischemic stroke die or are readmitted within one year, researchers report in Stroke: Journal of the American Heart Association.

17 Dec 2010

Ischemic stroke patients at substantial risk once leaving the hospital: Study

A UCLA-led has study found that after leaving the hospital, nearly two-thirds of Medicare beneficiaries hospitalized for acute ischemic stroke either died or were rehospitalized within a year.

17 Dec 2010

Researchers contribute important expertise to new landmark study of medulloblastoma

Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children. The large multicenter study defines the genetic landscape of this cancer, and holds intriguing clues to gene changes on signaling pathways that may become fruitful targets for future therapies.

17 Dec 2010

Researchers discover new way to prevent spread of cancer

Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way -- by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because preventing the development of these "feet" also eliminates the action of proteins present in the feet that burn through intact tissue and let cancer cells enter new cells.

17 Dec 2010

Medical Research News

Exciting progress made in MS research during 2010

Health Care at Home: Trends and issues

PwC: Top Health Industry Issues of 2011

U of A student wins annual master's thesis competition for research on light-sensitive drug for prostate cancer

Researchers demonstrate that monensin antibiotic prevents prostate cancer cell growth

Sanofi-aventis, Oxford University to conduct multi-phase oncology research in India

Avila, sanofi-aventis enter global alliance to discover targeted covalent drugs for treatment of cancers

Researchers examine socio-economic consequences of hypersomnia

Study finds second skin barrier structure may play a role in eczema development

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

Improved brain-machine technologies

Completely fearless woman stirs scientific interest

Early intervention can improve core symptoms of ASD in young children: Study

NIAID renews funding of PRIME to develop mathematical models to study influenza infection

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

23andMe project aims at validating highly scalable pharmacogenomics research

Study highlights death or rehospitalization rates for Medicare beneficiaries with ischemic stroke

Ischemic stroke patients at substantial risk once leaving the hospital: Study

Researchers contribute important expertise to new landmark study of medulloblastoma

Researchers discover new way to prevent spread of cancer

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News